Advertisement
Editorial| Volume 30, ISSUE 2, P208-210, February 2022

Download started.

Ok

To Activate or Not to Activate: An Integral Question for Self-Guided Behavioral Activation Interventions for Older Adults with Sub-Clinical Depression

Published:July 08, 2021DOI:https://doi.org/10.1016/j.jagp.2021.07.003
To Activate or Not to Activate: An Integral Question for Self-Guided Behavioral Activation Interventions for Older Adults with Sub-Clinical Depression
Previous ArticleCan We Prevent Depression in At-Risk Older Adults Using Self-Help? The UK SHARD Trial of Behavioral Activation
Next ArticleA Comparison of Physician-Assisted/Death-With-Dignity-Act Death and Suicide Patterns in Older Adult Women and Men
      Global statistics suggest that although nearly 15% of older adults by the age of 65 meet criteria for a major depressive episode
      • Patel V
      • Chisholm D
      • Parikh R
      • et al.
      Addressing the burden of mental, neurological, and substance use disorders: key messages from disease control priorities, 3rd edition.
      Lancet. 2016; 387: 1672-1685https://doi.org/10.1016/S0140-6736(15)00390-6
      , many other older adults face sub-threshold levels of depression that still cause functional impairment and reduced quality of life. Despite concerns with polypharmacy, psychotropic medications continue to be a widely used intervention for depression among this population
      • Arthur A
      • Savva GM
      • Barnes LE
      • et al.
      Changing prevalence and treatment of depression among older people over two decades.
      Bri J Psychiatry. 2020; 216: 49-54https://doi.org/10.1192/bjp.2019.193
      even in the presence of effective non-pharmacological evidence-based treatments such as behavioral activation (BA).
      • Orgeta V
      • Brede J
      • Livingston G.
      Behavioural activation for depression in older people: systematic review and meta-analysis.
      Bri J Psychiatry. 2017; 211: 274-279https://doi.org/10.1192/bjp.bp.117.205021
      Therefore, innovation is needed in research aimed at developing, implementing, and evaluating non-pharmacological scalable interventions to treat clinical and sub-clinical depression among older adults with and without comorbidities.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Geriatric Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Patel V
        • Chisholm D
        • Parikh R
        • et al.
        Addressing the burden of mental, neurological, and substance use disorders: key messages from disease control priorities, 3rd edition.
        Lancet. 2016; 387: 1672-1685https://doi.org/10.1016/S0140-6736(15)00390-6
        View in Article
        • Arthur A
        • Savva GM
        • Barnes LE
        • et al.
        Changing prevalence and treatment of depression among older people over two decades.
        Bri J Psychiatry. 2020; 216: 49-54https://doi.org/10.1192/bjp.2019.193
        View in Article
        • Orgeta V
        • Brede J
        • Livingston G.
        Behavioural activation for depression in older people: systematic review and meta-analysis.
        Bri J Psychiatry. 2017; 211: 274-279https://doi.org/10.1192/bjp.bp.117.205021
        View in Article
        • Gilbody S
        • Brabyn S
        • Mitchell A
        • et al.
        Can we prevent depression in at-risk older adults using self-help? The UK SHARD trial of Behavioural Activation.
        Am J Geriatr Psychiatry. 2022; 30: 197-207https://doi.org/10.1016/j.jagp.2021.06.006
        View in Article
        • Proctor E
        • Silmere H
        • Raghavan R
        • et al.
        Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda.
        Adm Policy Ment Health. 2011; 38: 65-76https://doi.org/10.1007/s10488-010-0319-7
        View in Article
        • Bower P
        • Richards D
        • Lovell K.
        The clinical and cost-effectiveness of self-help treatments for anxiety and depressive disorders in primary care: a systematic review.
        Br J Gen Pract. 2001; 51: 838-845
        View in Article
        • Jimenez DE
        • Syed S
        • Perdomo-Johnson D
        iHOLA, amigos! Toward preventing anxiety and depression in older Latinos.
        Am J Geriatr Psychiatry. 2018; 26: 250-256https://doi.org/10.1016/j.jagp.2017.06.020
        View in Article

      Article info

      Publication history

      Published online: July 08, 2021
      Accepted: July 1, 2021
      Received: July 1, 2021

      Footnotes

      The data has not been previously presented orally or by poster at scientific meetings.

      Daniel E. Jimenez does not have any conflicts to declare.

      Identification

      DOI: https://doi.org/10.1016/j.jagp.2021.07.003

      Copyright

      © 2021 Published by Elsevier Inc. on behalf of American Association for Geriatric Psychiatry.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX